The Tyrosine 343 Residue of Nucleophosmin (NPM)-Anaplastic Lymphoma Kinase (ALK) Is Important for Its Interaction with SHP1, a Cytoplasmic Tyrosine Phosphatase with Tumor Suppresso...

Por Hegazy, Samar A., Wang, Peng, Anand, Mona, Ingham, Robert J., Gelebart, Pascal, Lai, Raymond
Publicado em 2010

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis

Por Al Bashir, Samir, Alshalalfa, Mohammed, Hegazy, Samar A, Dolph, Michael, Donnelly, Bryan, Bismar, Tarek A
Publicado em 2014

The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy

Por Huang, Kuo-Cheng, Alshalalfa, Mohammed, Hegazy, Samar A, Dolph, Michael, Donnelly, Bryan, Bismar, Tarek A
Publicado em 2014

IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma

Por Dien Bard, Jennifer, Gelebart, Pascal, Anand, Mona, Zak, Zoulika, Hegazy, Samar A., Amin, Hesham M., Lai, Raymond
Publicado em 2009

Fusion Tyrosine Kinase NPM-ALK Deregulates MSH2 and Suppresses DNA Mismatch Repair Function: Novel Insights into a Potent Oncoprotein

Por Young, Leah C., Bone, Kathleen M., Wang, Peng, Wu, Fang, Adam, Benjamin A., Hegazy, Samar, Gelebart, Pascal, Holovati, Jelena, Li, Liang, Andrew, Susan E., Lai, Raymond
Publicado em 2011